Series D funding round for Maze Therapeutics raising $120M in December 2024
Series D funding round for Maze Therapeutics raising $120M in December 2024
| Investor | Firm Type | Partner |
|---|
| Venture Capital | — | |
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$500M
Top Valuation
-
Maze Therapeutics raised $120M in a Series D round.
The round was announced on 12/01/24.
The round was led by Deep Track Capital, Frazier Life Sciences.